Few conditions cause more silent embarrassment in men than enlarged breast tissue. Gynecomastia — the benign proliferation of glandular breast tissue in males — affects roughly 30% of adolescent boys and up to 65% of older men at some point in life, according to the Urology Care Foundation. Most cases are benign, many resolve spontaneously, and most men never seek evaluation. Some, however, mask hormonal disorders or, rarely, breast cancer that requires urgent attention.
What Gynecomastia Actually Is
Gynecomastia is true glandular tissue growth driven by an imbalance in the estrogen-to-androgen ratio. It is distinct from pseudogynecomastia, which is fat accumulation without glandular proliferation. The distinction matters because pseudogynecomastia responds to weight loss while true gynecomastia generally requires hormonal correction or surgical removal.
Histologically, true gynecomastia shows ductal proliferation, periductal edema, and fibroblastic stroma. Early disease (under 6 to 12 months) is potentially reversible. Long-standing gynecomastia (over 12 months) usually has fibrosis that does not regress with hormonal correction alone.
What Causes Gynecomastia
The unifying mechanism is a relative excess of estrogen activity at the breast. Causes are conventionally divided into physiologic, pathologic, drug-induced, and idiopathic.
Physiologic gynecomastia occurs in three life stages: neonatal (from maternal estrogens, resolves in weeks), pubertal (peak around age 13 to 14, present in roughly 30 to 60% of boys, usually resolves within 1 to 2 years), and senile (from declining testosterone with relatively preserved peripheral aromatization).
Pathologic causes include hypogonadism (primary or secondary — see hypogonadism guide), Klinefelter syndrome, hyperthyroidism, chronic kidney disease, cirrhosis, and certain tumors (testicular germ cell tumors producing hCG, adrenal tumors producing estrogen, hCG-secreting tumors elsewhere). Hyperprolactinemia from a pituitary tumor is another notable cause.
Drug-induced gynecomastia accounts for up to 25% of adult cases. Common offenders include spironolactone, ketoconazole, cimetidine, finasteride, anabolic steroids (during the post-cycle estrogen rebound), antipsychotics, antiretrovirals, calcium channel blockers, and recreational substances (alcohol, marijuana, opioids). Anabolic steroid abuse is now one of the leading reasons young men present to plastic surgery clinics for gynecomastia correction.
Symptoms and Patterns
The hallmark is palpable, often tender, glandular tissue beneath the nipple-areolar complex. Most cases are bilateral but asymmetry is common, and unilateral involvement is also possible. Tenderness is more typical in the active proliferative phase of recent-onset disease. Established, long-standing gynecomastia is usually firm, painless, and stable.
The clinical concern that should never be missed is male breast cancer, which accounts for less than 1% of all breast cancers but presents similarly in some respects. Features that raise suspicion for malignancy include a hard, fixed, eccentric (off-center) mass, skin or nipple retraction, bloody or unilateral nipple discharge, axillary lymphadenopathy, and a strong family history of breast cancer or BRCA mutations. Rapidly progressive unilateral gynecomastia in an older man warrants urgent evaluation.
When to seek emergency care: Call your doctor or visit a clinic promptly if you discover a hard, fixed lump in the breast, skin or nipple retraction, bloody nipple discharge, or rapidly enlarging unilateral breast tissue — these features can indicate male breast cancer rather than gynecomastia.
How Gynecomastia Is Diagnosed
Evaluation begins with a focused history covering onset, progression, tenderness, medications and supplements (including anabolic steroids), alcohol use, family history, and symptoms suggestive of liver, kidney, thyroid, or pituitary disease. Physical exam confirms glandular tissue (firm rubbery disc beneath the areola) versus fat (soft, lacks discrete edge), assesses size and symmetry, and identifies any concerning features that suggest malignancy.
Recommended labs include a morning total and free testosterone, estradiol, LH, FSH, prolactin, TSH, hCG (to screen for testicular germ cell tumor), and liver and kidney function. Testicular exam and scrotal ultrasound are warranted in cases with palpable testicular abnormality or elevated hCG. The Mayo Clinic recommends mammography or breast ultrasound for any concerning unilateral, hard, or fixed mass.
Treatment Options
Treatment depends on cause, duration, and patient preference. Many cases — particularly pubertal gynecomastia and short-duration drug-induced cases — resolve with watchful waiting or removal of the offending exposure. Discontinuation of an offending medication often produces regression within 6 to 12 months when the gynecomastia is recent.
Pharmacologic therapy works best in early, painful, proliferative gynecomastia. Tamoxifen (10 to 20 mg daily for 3 to 6 months) is the most studied agent and produces meaningful regression in 60 to 80% of treated cases. Raloxifene is an alternative. Aromatase inhibitors (anastrozole) have weaker evidence and are not first-line. None of these agents are FDA-approved specifically for gynecomastia, although tamoxifen has Endocrine Society endorsement for off-label use in selected cases.
Surgical correction is the definitive treatment for established gynecomastia that has not responded to medical therapy or that is greater than 12 months old. Options include subcutaneous mastectomy (removal of glandular tissue), liposuction (best for predominantly fatty pseudogynecomastia), and combined approaches. Cash prices for outpatient gynecomastia surgery typically run $4,000 to $10,000 in the US, depending on technique, surgeon, and region. Insurance coverage is variable — most plans deny coverage as cosmetic, but documented severe psychological distress or pain may support medical necessity in some cases.
When to See a Doctor
Any new or progressive breast enlargement in a man warrants evaluation, particularly in the absence of an obvious cause like recent puberty or significant weight gain. Tender, painful, or bilateral gynecomastia of recent onset deserves a structured workup. Unilateral, hard, or fixed masses should be evaluated promptly to rule out male breast cancer. Adolescents with persistent gynecomastia beyond 18 to 24 months are reasonable candidates for evaluation and consideration of treatment.
For related concerns, see estrogen dominance in men, high prolactin in men, and the medical conditions hub.
Frequently Asked Questions
Will gynecomastia go away on its own?
Often yes. Pubertal gynecomastia resolves in roughly 75 to 90% of boys within 1 to 2 years. Drug-induced gynecomastia frequently regresses after the offending agent is stopped, particularly if it has been present less than 6 to 12 months. Established adult gynecomastia present beyond a year is less likely to regress without treatment.
Can losing weight fix gynecomastia?
Weight loss helps pseudogynecomastia (fatty enlargement) substantially. True glandular gynecomastia does not respond to weight loss alone, although weight loss may improve the cosmetic appearance and reduce aromatase activity in adipose tissue. Many men have a combination, in which case weight loss helps but does not fully resolve the issue.
Is surgery the only permanent solution?
For established gynecomastia of more than 12 months duration, surgical correction is the most reliable long-term option. Pharmacologic therapy works best in early, recent-onset cases. Watchful waiting is reasonable for many adolescents and for short-duration drug-induced cases.
Does anabolic steroid use cause gynecomastia?
Yes — exogenous androgens are aromatized to estradiol, and the post-cycle drop in testosterone with persistent estrogen activity is a classic trigger. Many anabolic steroid users develop gynecomastia that requires surgical correction. Aromatase inhibitors and SERMs are commonly used in cycles, although unsupervised use carries its own risks.
The Bottom Line
Gynecomastia is common, usually benign, and often treatable. The first task is sorting out the cause — physiologic, drug-related, or pathologic — and ruling out male breast cancer in concerning presentations. Early proliferative cases respond to medical therapy; established disease usually requires surgery for correction. A focused evaluation with a primary care physician, endocrinologist, or surgeon is the practical next step for any man bothered by persistent breast enlargement.